Invention Grant
- Patent Title: Anti-serum albumin binding variants
- Patent Title (中): 抗血清白蛋白结合变体
-
Application No.: US13202353Application Date: 2010-02-17
-
Publication No.: US09534043B2Publication Date: 2017-01-03
- Inventor: Elena De Angelis , Carolyn Enever , Haiqun Liu , Christopher Plummer , Oliver Schon
- Applicant: Elena De Angelis , Carolyn Enever , Haiqun Liu , Christopher Plummer , Oliver Schon
- Applicant Address: GB
- Assignee: Glaxo Group Limited
- Current Assignee: Glaxo Group Limited
- Current Assignee Address: GB
- Agent Jason C. Fedon; Edward R. Gimmi
- International Application: PCT/EP2010/052008 WO 20100217
- International Announcement: WO2010/094723 WO 20100826
- Main IPC: C07K16/18
- IPC: C07K16/18 ; C07K14/56 ; C07K14/575 ; C07K16/28
Abstract:
The invention relates to improved variants of the anti-serum albumin immunoglobulin single variable domain DOM7h-11, as well as ligands and drug conjugates comprising such variants, compositions, nucleic acids, vectors and hosts.
Public/Granted literature
- US20110305696A1 ANTI-SERUM ALBUMIN BINDING VARIANTS Public/Granted day:2011-12-15
Information query
